Finance

Lists
009290:KRX
Kwangdong Pharmaceutical Co Ltd
â‚©6,340.00
-0.63%
(-40.00) 1D
Sep 11, 3:30:18 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 009290...
Open
â‚©6,310
High
â‚©6,360
Low
â‚©6,280
Mkt. cap
315.73B
Avg. vol.
144.91K
Volume
78.69K
Dividend
1.58%
Quarterly dividend
â‚©25
Ex-dividend date
Mar 31, 2026
P/E ratio
12.46
52-wk high
â‚©12,800
52-wk low
â‚©5,150
EPS
â‚©509
Shares outstanding
49.80M
No. of employees
1K
Open
â‚©6,310
High
â‚©6,360
Low
â‚©6,280
Mkt. cap
315.73B
Avg. vol.
144.91K
Volume
78.69K
Dividend
1.58%
Quarterly dividend
â‚©25
Ex-dividend date
Mar 31, 2026
P/E ratio
12.46
52-wk high
â‚©12,800
52-wk low
â‚©5,150
EPS
â‚©509
Shares outstanding
49.80M
No. of employees
1K
About Kwangdong Pharmaceutical Co Ltd
CEOSeong Won Choi
Employees1K
Founded1963
Headquarters-
SectorPharmaceutical industry
Websiteekdp.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
444.52B
412.10B
410.85B
439.82B
Cost of goods sold
364.37B
331.32B
336.56B
363.42B
Cost of revenue
364.37B
331.32B
336.56B
363.42B
Research and development expenses
2.31B
2.52B
3.02B
2.72B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
64.25B
63.37B
59.62B
68.37B
Operating expense
69.28B
68.45B
66.77B
73.58B
Total operating expenses
433.65B
399.77B
403.33B
436.99B
Operating income
10.87B
12.33B
7.52B
2.82B
Other non operating income
163.53M
474.20M
-904.17M
163.97M
EBT including unusual items
14.32B
7.59B
6.56B
4.44B
EBT excluding unusual items
10.58B
4.88B
8.31B
2.54B
Income tax expense
3.21B
3.82B
1.66B
1.28B
Effective tax rate
22.45%
50.37%
25.29%
28.78%
Other operating expenses
503.83M
440.15M
516.85M
310.45M
Net income
10.79B
3.93B
4.40B
2.71B
Net profit margin
2.43%
0.95%
1.07%
0.62%
Earnings per share
-
-
-
-
Interest and investment income
1.50B
1.31B
1.85B
1.87B
Interest expense
-2.64B
-2.69B
-2.97B
-3.08B
Net interest expenses
-1.15B
-1.38B
-1.12B
-1.21B
Depreciation and amortization charges
1.66B
1.75B
1.90B
1.89B
EBITDA
15.46B
17.02B
13.15B
8.44B
Gain or loss from assets sale
-517.21M
-156.85M
-77.73M
-134.74M
AI content may include mistakes. Learn more
Google apps